Adolescence is a critical period in the development of atherosclerosis ... or other diseases such as dyslipidemia, obesity, arterial hypertension and diabetes. Dyslipidemia in childhood and ...

PCSK9 is implicated in various processes such as lipid metabolism, atherosclerosis, oxidative stress, inflammatory responses, thrombosis, and apoptosis. It is closely linked to ischemic stroke through ...

Heart disease is a term used to describe a constellation of conditions that can affect the heart and/or its valves, vessels, structure, electrical system, or coronary arteries. Though each disease ...

Solbinsiran sodium is under clinical development by Eli Lilly and Co and currently in Phase II for Mixed Dyslipidemia. According to GlobalData, Phase II drugs for Mixed Dyslipidemia have a 74% phase ...

AZD-1705 is under clinical development by AstraZeneca and currently in Phase I for Dyslipidemia. According to GlobalData, Phase I drugs for Dyslipidemia have a 68% phase transition success rate (PTSR) ...

"The exponential rise in technology powered by [artificial intelligence (AI)] is defining new frontiers in cardiovascular care, with innovations that span novel diagnostic modalities, new digital ...

A study published in Nature Cardiovascular Research identifies an intrinsic anti-inflammatory factor that can be therapeutically targeted to reduce vascular inflammation and atherosclerosis.

Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China Center of Clinical Pharmacology, the Third Xiangya Hospital, Central South University, ...

This process is known as atherosclerosis. Having both a high CAC score and high cholesterol levels could increase a person’s risk of developing heart disease, but having one high score does not ...

In this review, we will describe the recent progress in dyslipidemia of AV using metabolomics and lipidomics advances. We will begin with a literature overview of dyslipidemia of AV, followed by a ...

Dyslipidemia is a major risk factor contributing ... a process that is central to the pathogenesis of atherosclerosis. In ART-naive patients, the proinflammatory state may contribute to mortality ...